Investment Details
Investor Type
Private Investment Firm
Asset Class Focus
Private Equity, Venture Capital, Real Estate, Fixed Income (Debt and Bonds)
Stage Focus
Seed, Early Stage, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States, Australia, China, India, New Zealand
Industries Focus
- Financial Services
- Technology
- Healthcare
- Real Estate
- Software
- Artificial Intelligence
- Life Sciences
- Pharmaceuticals
- Semiconductors
- Biotechnology
- Deep Tech
- Cloud Infrastructure
- Advanced Manufacturing
- 5G Innovation
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 1999
Bridgewest Group is a privately held global investment firm with over $3 billion in private capital, focusing on empowering people through business investment. The firm has a 25-year history of building transformative businesses across life sciences, software, semiconductors, and advanced manufacturing. With a presence in the United States, Australia, New Zealand, and Asia, Bridgewest Group actively partners with founders, governments, and research institutions to unlock high-growth opportunities and accelerate innovation. The firm's portfolio includes over 40 companies spanning sectors critical to the future of healthcare and technology, including AI, biologics manufacturing, gene therapy, drug development, cloud infrastructure, and 5G innovation. Bridgewest Group also manages a significant real estate and fixed income portfolio, including commercial properties, development projects, and tailored credit strategies that generate stable returns. The firm's robust eco-community, including its Global Capability Center - Bridgewest India, facilitates functional support so CEOs can turn their ideas into prosperous companies. Nearly 100% of portfolio CEOs stay with Bridgewest Group to form new ventures after exits. The firm's investment strategy emphasizes people empowerment, collaborative mentorship, and capital infusion to move the brightest entrepreneurs forward, from idea inception through exit. As private investors, Bridgewest Group is not beholden to other investors nor artificial timeframes, allowing them to maximize outcomes for everyone based on merit instead of timeline adherence. The firm's operating partners and subject matter experts guide entrepreneurs to successful financial outcomes, providing deep operational support—from capital markets and legal structuring to product strategy and executive mentoring—ensuring each venture has the tools and guidance to scale sustainably. Notable achievements include launching BioDuro (now the world’s third-largest CRDMO), acquiring and transforming Pfizer’s Australian facilities into leading CDMO BioCina, and engineering successful exits such as RapidBridge to Qualcomm and Wavious to a Fortune 5 tech company. Bridgewest Group's life's work has empowered people and ideas to thrive, working with industry leaders like AT&T, Advent International, Intel, Pfizer, Qualcomm, and Verizon, driving billion-dollar exits and building lasting legacies.
Requirements
- Innovative companies in technology and healthcare sectors seeking capital and strategic support
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- BioDuro
- BioCina
- RapidBridge
- Wavious
- Projectworks
Claim this Investor
Are you an official representative of Bridgewest Group?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim